Última Hora: "" Mon, 19 Nov 2018 07:42:37 GMT    "«Operadoras preparam aumento dos preços» - Negócios - A Bola" Mon, 19 Nov 2018 07:31:37 GMT    "Lisboa vai ser a ?escolha número um? para investir em imobiliário na Europa - ECO Economia Online" Sun, 18 Nov 2018 14:03:45 GMT    "Fiscais da Carris vão começar a passar multas de estacionamento - Jornal Económico" Sun, 18 Nov 2018 09:29:00 GMT    "Gasóleo ficou mais caro 11 cêntimos num ano - Sul Informacao" Sun, 18 Nov 2018 12:15:00 GMT    "SIMAB vai instalar cidade comercial na China - Jornal Económico" Sun, 18 Nov 2018 17:13:00 GMT    "Número de empresas a fechar duplicou - Dinheiro Vivo" Mon, 19 Nov 2018 07:17:13 GMT    "Apagão de rede bancária em Moçambique deve-se a falta de pagamento pelo 'software' - fornecedor - Diário de Notícias - Lisboa" Sun, 18 Nov 2018 21:26:29 GMT    "Trotinetes da Lime vão ter concorrência. VOI fecha financiamento para abrir em Portugal - Jornal Económico" Mon, 19 Nov 2018 00:01:00 GMT    "Banco CTT ?não se tem ressentido? de situação dos CTT - Jornal de Negócios - Portugal" Sun, 18 Nov 2018 12:00:41 GMT      Para mais notícias, clique aqui.

Área de Acesso
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Queda de
--59.00 (+0.83%) SCHERING PLOUGH C - [Ticker: SGP]Gráfico SCHERING PLOUGH C  Notícias SCHERING PLOUGH C  Download de Históricos Metastock SCHERING PLOUGH C e Outros  Análise Técnica SCHERING PLOUGH C  
Última Trade290,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade2018-11-13 - 00:00:00Price-Target 1 Ano0,000
Variação--59.00 (+0.83%)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Máximo290,200Pagamento Dividendo
Mínimo290,000Data Ex-Dividendo
Fecho Anterior349,000Yield
Volume160Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de SCHERING PLOUGH C -  [Ticker: SGP]
Mudar para Gráfico de Análise Técnica Interactiva de SCHERING PLOUGH C

Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C:
Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C.

 Notícias sobre SCHERING PLOUGH C [SGP]:   (ordenadas por relevância)

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors
Prior to becoming CEO of LifeWatch AG in 2014, Dr. Rietiker held executive roles at Roche, Boehringer Mannheim, Schering Plough, Covance and as CEO of Centerpulse (formerly Sulzer Medica). Additionally, he has been an investor, executive and Board ...

e mais »

Snelson Named AASV New Executive Director
Pork Magazine
For the first time in 25 years, the American Association of Swine Veterinarians (AASV) will have a new Executive Director, Dr. Harry Snelson. Snelson, who is the current AASV Director of Communications, has had a long association with the organization ...

National Hog Farmer

Snelson named AASV executive director
National Hog Farmer
... Medicine and then spent 10 years as the swine veterinarian for Carroll's Foods in Warsaw, N.C. In 2000, he accepted a position as a swine technical services veterinarian with Schering-Plough Animal Health before leaving in 2003 to become the ...

??????? (????)

??? ???? ?, ??? ?? ???? 10?
??????? (????)
??????? ???? ?? ??? ????? ? ?? C??? ???? ????? ??? ??? ?? ???. ?? ??? ???? Wnt ?????? ???? ??? ???? ???. ? ??? ?????(Schering-Plough, S-P)?? ??? ?? ??? ...


Keytruda sales power Merck to quarterly beat
(Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.


Anti-Viral Drugs Market Potential Growth, Share, Demand and ...
focusing top manufacturers in Anti-Viral Drugs market, with Production, price, revenue and market share for each manufacturer, covering top players: ? Schering-Plough, Gilead, AstraZeneca, Cipla, Roche, Merck & Co, Bristol-Myers-Squibb, GlaxoSmithKline ...

e mais »

The Pharmaceutical Journal

Hepatitis C: tackling the silent killer
The Pharmaceutical Journal
1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...

Merck, Schering-Plough set to complete merger
NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.


Pharma Billionaire Charged With Penny Stock Fraud
Investigators allege an investor named Barry C. Honig served as the ringleader of the scheme. In each of three ... They sold that company, the developer of some of the first sustained release formulations, to Schering-Plough in 1986 for $836 million ...

e mais »

Business Wire (press release)

Science Exchange Adds Allergan EVP & Chief R&D Officer David ...
Business Wire (press release)
PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, Inc. announced today that C. David Nicholson, Ph.D., EVP and Chief R&D Officer at Allergan, has joined the Science Exchange Board of Directors. Dr. Nicholson's experience includes over forty ...

e mais »

Cleveland Daily Banner

Alice Kaye Ames
Cleveland Daily Banner
She was a student at Bradley High School, and retired from Schering Plough as a secretary. She was dearly loved and will be greatly missed by all who knew her. She is preceded in death by her parents, George Myrick Hewitt and Alfrida Anderson Hewitt; ...

e mais »

Philanthropist and animal advocate Thomas J. Sabatino, Jr. joins the ...
Sabatino is currently Executive Vice President and General Counsel of Aetna, and has previously served in comparable positions at Hertz Global Holdings, Walgreens, United Airlines, Schering-Plough, Baxter International and American Medical International.

e mais »


Safe Stopping of Tocilizumab in RA: MTX Helps
Second-year data from the SURPRISE rheumatoid arthritis (RA) trial support the finding that many patients who achieve remission can safely stop ? or at least interrupt ? biologic treatment with tocilizumab. Such interruptions might reduce both costs ...

Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President ...
GlobeNewswire (press release)
In this position, she served as clinical lead for the hepatitis B and C and HIV portfolios. She previously worked at Schering-Plough Research Institute as a Director in Hepatology. Prior to working in industry, she was an Epidemic Intelligence Service ...


The top 5 highest-paid women biopharma executives in 2017
The wide gender gap higher up, though improved in recent years, persists: Women only hold a quarter of all C-suite level jobs, and less than 15% joined the board of directors. When they do make it to the top, women are overall paid far less .... A ...

Para mais notícias sobre SCHERING PLOUGH C clique aqui:

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters